The pharmaceutical industry engages in dialogue with stakeholders and the interested public on the issues of Switzerland as a pharmaceutical and research hub and its openness to business. During evening events, representatives from the world of politics, local business and industry discuss framework conditions and the challenges that come with the interdependence of local and global economies. In 2018, three public events were held in Zug, Solothurn and Basel.
Favourable framework conditions
All the speakers and podium participants stressed the importance of an open Switzerland that maintains good trading relations with the country’s most important export partners, especially the EU. The bilateral agreements are of utmost importance for export-oriented sectors such as the pharma industry in particular. To ensure that innovative medicines can continue to be developed in Switzerland, unbureaucratic access to European specialists is crucial. The interplay of local businesses and companies with an international focus is also considered important. To ensure that small and large companies both opt for a given location, the framework conditions must be optimally designed.
The Europe events were organized in partnership with economiesuisse/stark + vernetzt and the cantonal chambers of commerce, as well as other partners. They were well-attended and also enjoyed great media coverage. There was an article on the event in Solothurn, for example, in the Aargauer Zeitung, as well as two articles on the event in Zug in the Luzerner Zeitung and an article on the event in Basel. In addition, a Lunch Talk "Life Science : Underestimated Economic Factor Zurich" took place in cooperation with the Zurich Chamber of Commerce. The regional events will also be continued in 2019.
Wide range of activities on „Vorsprung Schweiz“
At the beginning of 2018, Interpharma redesigned the existing landing page www.vorsprung-schweiz.ch and tailored the content more specifically to the pharma industry. With the associated social media channels (Facebook, Twitter und LinkedIn), Interpharma is seeking to highlight the importance of an open Switzerland that maintains good relations with its main trading partners and the economic importance of the pharma industry on the basis of figures, reports and background stories. Above all Interpharma wants to illustrate through specific graphic and narrative content where and to what extent Switzerland’s openness and its bilateral agreements shape our everyday life. The campaign aimed at gaining support for the bilateral approach and raising public awareness.